Suppliers
Suppliers
Just as we believe that good health is the foundation of vibrant lives, thriving communities and forward progress, at Johnson & Johnson we also pride ourselves on fostering healthy supplier relationships that are built on trust, transparency and unparalleled innovation, quality and reliability.
Working with our valued partners, we uphold the highest standards for responsible sourcing and corporate citizenship, encouraging our suppliers to embrace new technologies, source innovative solutions and deliver new business models that contribute to our mutual objectives for growth, sustainability and streamlined processes.
Expand
Collapse
Featured stories
Suppliers
How Johnson & Johnson is helping people displaced by war and conflict restart their lives
A Partnership for Good program expands the company’s talent pool in Europe while assisting the mental and financial health of people displaced by conflict. Here’s how this novel initiative helped one young Ukraine War refugee get a foothold.
Our Company
Turning our supplier spend into societal good
Johnson & Johnson’s Global Supplier Diversity & Inclusion team is stepping up spending with social enterprises around the world to deepen its impact in local communities.
Our Company
Securing the future of surgery, one staple at a time
Faced with the challenge of improving stapling performance for consistent outcomes in challenging tissue, Ethicon drew inspiration from its broad and talented supplier base.
At Johnson & Johnson, our goal is to collaborate with our 45,000 suppliers around the world and use our collective ingenuity to change the trajectory of health for humanity.
Shashi Mandapaty
Chief Procurement Officer, Johnson & Johnson
More from Johnson & Johnson
Innovation
“I couldn’t speak, walk or sit.” Inside a rare autoimmune disease that attacks the muscles
Elisa Glass was diagnosed with dermatomyositis, which causes severe muscle weakness throughout the body. For Myositis Awareness Month, she shares her story.
Health & wellness
5 things we now know about bladder cancer
Paradigm-shifting new therapies are helping people with the disease lead longer, more comfortable lives. For Bladder Cancer Awareness Month, learn how Johnson & Johnson is helping to change the treatment landscape.
Innovation
What is IL-23?
This pro-inflammatory protein is the target of potential Johnson & Johnson medications that could help treat autoimmune conditions such as psoriasis, inflammatory bowel disease and rheumatoid arthritis.